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Dear Editor,
We read with great interest the publication of Ardeshiri et al.
[1] about the influence of localisation of intramedullary astro-
cytomas (IAs) on resectability and functional outcome.
The authors correlated tumour location and gross total re-
moval (GTR) in a series of 22 patients operated on for IAs
from June 1990 to October 2010.
The authors demonstrated a higher resection rate for cervi-
cal IAs when compared with other locations: GTR was
achieved in 90% of purely cervical tumours and in the 25%
of lesions located in the cervico-thoracic cord. In terms of
functional outcome, patients with cervical lesions deteriorated
in 30% of cases, while non-cervical patients deteriorated in
50% at a mean follow-up period of 10 years.
In our recent French multicentric study, we reviewed a
retrospective cohort of 95 patients operated on for IAs be-
tween 1984 and 2011. GTRwas achieved in 38% in the whole
series and postoperative deterioration occurred in 18% of pa-
tients independent of tumour location and histological grade.
We performed a sub-group analysis of this published study to
look at the correlation of the outcome with extent of surgical
resection (GTR) and the tumour location [8].
In terms of location, the tumours were distributed as fol-
lows: 38 (40%) thoracic, 27 (28.4%) cervical, 13 (13.6%)
cervico-thoracic, 11 conus terminalis (11.5%) and 6 (6.3%)
medulla-oblongata tumours.
We found a positive correlation (p = 0.002) between the
cervical location and higher rate of tumour removal: GTR
was achieved in 42% of cervical IAs, while for thoracic le-
sions GTR was achieved only in 23% of cases [8].
Deterioration of neurological outcome at 5 years of follow-
up was seen in 8% of patients with cervical IAs and in 17% of
patients with dorsal IAs.
Ourdata therefore confirm the findingsofArdeshiri et al.with
respect to the higher GTR and better outcome for cervical IAs in
comparison to dorsal tumours. In comparison to ependymomas,
IAs are infiltrative tumours with off-centre spread, which there-
fore explains the higher rates of neurological deterioration and
the lesser rates of GTR for these tumours [9].
The resection rate reported in the literature for IAs varies
from 12.5 to 72% [2–4, 7].
The difference of GTR and outcome for IAs based on lo-
cation of the tumour should be related to the regional variabil-
ity of spinal cord anatomy and its perfusion. The thoracic cord
perfusion is fragile, especially in the mid-thoracic region due
to the junctional supply between cervical and thoracic seg-
mental arterial contribution to the cord vasculature. Thus,
the thoracic cord perfusion is more likely to get compromised
during the dissection at the tumour cord interface that could
translate to irreversible neurological deficits.
The transverse diameter and the volume of the cord are largest
in the cervical segments, and decrease progressively to the seg-
mentT8.This isdue to thehigherabsolutenumberofwhitematter
fibres in the cervical region and the larger quantity of greymatter
in this region in comparison to the dorsal cord [5]. Thereby, the
ratio of the tumour volume compared with the cord volume (or
spinalcanalvolume) is likely tobe lower in thecervical than in the
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dorsalcord.Thecervical IAsarealso likely topresentearlier in the
illness due to the relatively higher eloquence of upper limb func-
tions that canbeperturbedby the involvementof theanteriorhorn
cells or roots. Typically, dorsal IAs present only when the long
tract function is perturbed. The earlier presentation of these tu-
mours allows a favourable cord tumour volume ratio, thereby
rendering the surgery easier and allowing a higher rate of GTR.
Cerebral gliomas are known to have a non-uniform ana-
tomical distribution with a preponderance to be located in
frontal and temporal lobes [6]. This could be due to develop-
mental, neurochemical or functional factors in their pathogen-
esis. Whether these molecular factors play a role in a non-
uniform distribution of more infiltrative tumours in the differ-
ent regions of the cord in IAs needs to be studied.
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